Systemic amyloidosis in inflammatory bowel disease: Retrospective study on its prevalence, clinical presentation, and outcome

Journal of Crohn's and Colitis

Volumn 4, Issue 3, 2010, Pages 269-274

  Serra, Isabel ^a   Oller, Blanca ^a   Mañosa, Míriam ^a,b   Naves, Juan E ^a   Zabana, Yamile ^a,b   Cabré, Eduard ^a,b   Domènech, Eugeni ^a,b  

^a HOSPITAL UNIVERSITARI GERMANS TRIAS I PUJOL   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

Crohn's disease; IBD; Systemic amyloidosis

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN; INFLIXIMAB; METHOTREXATE; SALAZOSULFAPYRIDINE; TACROLIMUS;

ADULT; AMYLOIDOSIS; ARTICLE; CLINICAL FEATURE; COHORT ANALYSIS; CONTROLLED STUDY; CROHN DISEASE; DRUG EFFICACY; DRUG TOLERABILITY; ENTERITIS; FEMALE; HUMAN; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; PATIENT REFERRAL; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS;

EID: 77955278772     PISSN: 18739946     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.crohns.2009.11.009     Document Type: Article

References (51)

1. Tena X., Olivé A. Amiloidosis: tesaurismosis proteica. Med Clin (Barc) 1994, 103:348-356.
2. Westermark P., Westermark G.T. Reflections on amyloidosis in Papua New Guinea. Phil Trans R Soc B 2008, 363:3701-3705.
3. Greenstein A.J., Sachar D.B., Aditya K., Panday N., Dikman S.H., Meyers S., et al. Amyloidosis and inflammatory bowel disease. A 50-year experience with 25 patients. Medicine (Baltimore) 1992, 71:261-270.
4. Wester A.L., Vatn M.H., Fausa O. Secondary amyloidosis in inflammatory bowel disease: a study of 18 patients admitted to Rikshospitalet University Hospital, Oslo, from 1962 to 1998. Inflamm Bowel Dis 2001, 7:295-300.
5. Höie O., Wolters F.L., Schouten L.J., Riis L., Solberg I.C., Mouzas I.A., et al. European Collaborative Study Group of Inflammatory Bowel Disease (EC-IBD). Ulcerative colitis: no rise in mortality in a European-wide population based cohort 10years after diagnosis. Gut 2007, 56:497-503.
6. Jess T., Loftus E.V., Harmsen W.S., Zinsmeister A.R., Tremaine W.J., Melton L.J., et al. Survival and cause specific mortality in patients with inflammatory bowel disease: a long-term outcome study in Olmsted County, Minnesota, 1940-2004. Gut 2006, 55:1248-1254.
7. Ho G.T., Chiam P., Drummond H., Loane J., Arnott I.D., Satsangi J. The efficacy of corticosteroid therapy in inflammatory bowel disease: analysis of a 5-year UK inception cohort. Aliment Pharmacol Ther 2006, 24:319-330.
8. Faubion W.A., Loftus E.V., Harmsen W.S., Zinsmeister A.R., Sandborn W.J. The natural history of corticosteroid therapy for inflammatory bowel disease: a population-based study. Gastroenterology 2001, 121:255-260.
9. Louis E., Collard A., Degroote E., Oger A.F., Belaiche J., Aboul Nasr El Yafi F.A. Behaviour of Crohn's disease according to the Vienna classification: changing pattern over the course of the disease. Gut 2001, 49:777-782.
10. Cosnes J., Cattan S., Blain A., Beaugerie L., Carbonnel F., Parc R., et al. Long-term evolution of disease behavior of Crohn's disease. Inflamm Bowel Dis 2002, 8:244-250.
11. Olsan E.S., Sussaman M.L. Nonespecific enterocolitis. Am J Roentgenol 1948, 60:471-485.
12. Shousha S., Lowdell C.P., Parkins R.A. The incidence of amyloidosis complicating inflammatory bowel disease. A prospective survey of 177 patients. Dis Colon Rectum 1986, 29:351-354.
13. Enríquez R., Cabezuelo J.B., Sirvent A.E., Ull Laita M., Reyes A., Reyes D.M. Crohn's disease with amyloid A amyloidosis and nephrotic syndrome. Nephron 1999, 81:123-124.
14. Garrido Serrano A., Guerrero Igea F.J., Hierro Guilmain C., Ruiz Lupiañez E., Palomo Gilá S. Respuesta favorable a la colchicina en la amiloidosis secundaria a la enfermedad inflamatoria intestinal. Gastroenterol Hepatol 2001, 24:196-198.
15. Martínez J.G., Saus C., Morey A., Alarcón A. Crohn's disease and renal amyloidosis. Acute renal failure Nefrología 2002, 22:397.
16. Fernández-Castroagudín J., Brage Varela A., Lens Neoa X.M., Martínez Castro J., Abdulkaderc I. Amiloidosis renal como manifestación clínica inicial de la enfermedad de Crohn. Gastroenterol Hepatol 2002, 25:395-397.
17. Béji S., Kaaroud H., Ben Moussa F., Goucha R., Abderrahim E., El Younsi F., et al. Renal amyloidosis complicating the outcome of chronic inflammatory colitis. Presse Med 2004, 33:862-865.
18. Iñarrairaegui Bastarrica M., Arín Letamendia A., Zozaya Urmeneta J.M., Rodríguez Gutiérrez C., Castán Martínez B., Amat Villegas I., et al. Enfermedad inflamatoria intestinal y amiloidosis. Gastroenterol Hepatol 2004, 27:260-263.
19. Elloumi H., Ben Slama A., Arfaoui D., Ghouma M., Sfar S., Ajmi S. Renal amyloidosis complicating Crohn's disease: report of two cases and review of literature. Tunis Med 2006, 84:253-255.
20. Seijo Ríos S., Barreiro Acosta M., Vieites Pérez-Quintela B., Iglesias Canle J., Forteza J., Domínguez Muñoz J.E. Secondary amyloidosis in Crohn's disease. Rev Esp Enferm Dig 2008, 100:792-797.
21. Pérez Marín J.C., Acosta de Bilbao F., Santos Moyano Z., Mohahamad Tubío A.M. Amiloidosis renal secundaria como primera manifestación de una enfermedad de Crohn. Rev Clin Esp 2008, 208:474-479.
22. Basili E., Cazo M., Laugier R. Secondary amyloidosis complicating ulcerative colitis. Gastroenterol Clin Biol 2002, 26:529-531.
23. Kostadinova-Kunovska S., Petrusevska G., Grcevska L., Banev S., Dzikova S., Bogoeva B., et al. The possible pathogenesis of AA type amyloidosis in a patient with ulcerative colitis and renal cell carcinoma. Acta Med Croatica 2006, 60:251-254.
24. Kahn E., Markowitz J., Simpser E., Aiges H., Daum F. Amyloidosis in children with inflammatory bowel disease. J Pediatr Gastroenterol Nutr 1989, 8:447-453.
25. Heras M., Sánchez R., Sáiz A., Fernández-Reyes M., Molina A., Alvarez-U de F. Renal amyloidosis in a female with familial Mediterranean fever: clinical response to treatment with colchicine and infliximab. Nefrología 2009, 29:373-375.
26. Manna R., Cerquaglia C., Curigliano V., Fonnesu C., Giovinale M., Verrecchia E., et al. Clinical features of familial Mediterranean fever: an Italian overview. Eur Rev Med Pharmacol Sci 2009, 13(1):51-53.
27. Yamazaki K., Yamazaki T., Masumoto J., Suzuki A., Yazaki M., Agematsu K. Familial Mediterranean fever as representative autoinflammatory disease. Rinsho Byori 2009, 57:371-381.
28. Vinceneux P., Pouchot J. From familial Mediterranean fever to amyloidosis. Presse Med 2005, 34:958-966.
29. Fidder H., Chowers Y., Ackerman Z., Pollak R.D., Crusius J.B., Livneh A., et al. The familial Mediterranean fever (MEVF) gene as a modifier of Crohn's disease. Am J Gastroenterol 2005, 100:338-343.
30. Fidder H.H., Chowers Y., Lidar M., Sternberg M., Langevitz P., Livneh A. Crohn disease in patients with familial Mediterranean fever. Medicine (Baltimore) 2002, 81:411-416.
31. Renda M.C., Civitavecchia G., Fabiano C., Sammarco P., Cottone M. Familial Mediterranean fever gene (MEVF) mutations in Crohn's disease in a Mediterranean area. Inflamm Bowel Dis 2008, 14:1313.
32. Swarowsky B. Case report: secondary amyloidosis in ulcerative colitis-successful treatment with colchicine. Z Gastroenterol 1997, 35:XVIII.
33. Menges M., Steffen H.M. Secondary amyloidosis in ulcerative colitis-successful treatment with colchicine. Z Gastroenterol 1996, 34:753-756.
34. Meyers S., Janowitz H.D., Gumaste V.V., Abramson R.G., Berman L.J., Venkataseshan V.S., et al. Colchicine therapy of the renal amyloidosis of ulcerative colitis. Gastroenterology 1988, 94:1503-1507.
35. Garrido Serrano A., Guerrero Igea F.J., Hierro Guilmain C., Ruiz Lupiáñez E., Palomo Gil S. Good response to colchicine in amyloidosis secondary to inflammatory bowel disease. Gastroenterol Hepatol 2001, 24:196-198.
36. Hillemand P., Loygue J., Richet G., Dalsace J., Delavierre P. Hemorrhagico-purulent and ulcerative rectocolitis complicated by diffuse amylosis. Total colectomy; favorable action on the amylosis. Presse Med 1964, 72:1571-1574.
37. Fitchen J.H. Amyloidosis and granulomatous ileocolitis. Regression after surgical removal of the involved bowel. N Engl J Med 1975, 292:352-353.
38. Ravid M., Shapira J., Kedar I., Feigl D. Regression of amyloidosis secondary to granulomatous ileitis following surgical resection and colchicine administration. Acta Hepatogastroenterol (Stuttg) 1979, 26:513-515.
39. Mandelstam P., Mitchell B., Simmons D.E. Regression of amyloid in Crohn's disease after bowel resection. A 19-year follow-up. J Clin Gastroenterol 1989, 11:324-326.
40. Cerdán F.J., Díez M., Pérez de Oteiza C., Martínez S., Hernández Merlo F., Balibrea J.L. Renal amyloidosis in a case of Crohn disease with colonic and rectal involvement. Rev Esp Enferm Dig 1991, 80:123-126.
41. Weterman I.T., Biemond I., Peña A.S. Mortality and causes of death in Crohn's disease. Review of 50years' experience in Leiden University Hospital. Gut 1990, 31:1387-1390.
42. Rashid H., Blake D., Gokal R., Gooptu D., Kerr D.N. The association of renal amyloidosis with regional enteritis (Crohn's disease). Report of two cases and review of the literature. Clin Nephrol 1980, 14:154-157.
43. Verschueren P., Lensen F., Lerut E., Claes K., De Vos R., Van Damme B., et al. Benefit of anti-TNFalpha treatment for nephrotic syndrome in a patient with juvenile inflammatory bowel disease associated spondyloarthropathy complicated with amyloidosis and glomerulonephritis. Ann Rheum Dis 2003, 62:368-369.
44. Callejas Rubio J.L., Ortego Centeno N., Cárdeña Pérez C., Navas-Parejo A. Infliximab and amyloidosis secondary to inflammatory bowel diseases. Med Clin (Barc) 2005, 124:757-758.
45. Iizuka M., Konno S., Horie Y., Itou H., Shindo K., Watanabe S. Infliximab as a treatment for systemic amyloidosis associated with Crohn's disease. Gut 2006, 55:744-745.
46. Boscá M.M., Pérez-Baylach C.M., Solis M.A., Antón R., Mayordomo E., Pons S., et al. Secondary amyloidosis in Crohn's disease: treatment with tumour necrosis factor inhibitor. Gut 2006, 55:294-295.
47. Fernández-Nebro A., Ureña I., García-Vicuña R., Irigoyen M.V. Anti-TNF-alpha for treatment of amyloidosis associated with Crohn's disease. Gut 2006, 55:1666-1667.
48. Park Y.K., Han D.S., Eun C.S. Systemic amyloidosis with Crohn's disease treated with infliximab. Inflamm Bowel Dis 2008, 14:431-432.
49. Metyas S., Forrester D.M., Arkfeld D.G., Ehresmann G.R. Infliximab treatment of familial Mediterranean fever and its effect on secondary AA amyloidosis. Clin Rheumatol 2004, 10:134-137.
50. Yüksel S., Yalçinkaya F., Acar B., Oztürk B., Ozçakar Z.B., Ekim M. Clinical improvement with infliximab in a child with amyloidosis secondary to familial Mediterranean fever. Rheumatology (Oxford) 2006, 45:1307-1308.
51. Tamura H., Hasegawa K. A review for recent advances in AA amyloid research and therapeutic approach to AA amyloidosis complicating rheumatoid arthritis. Nihon Rinsho Meneki Gakkai Kaishi 2009, 32:35-42.